Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study

OBJECTIVES: Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19, although the clinical outcome of such treatment remains unclear. This study evaluated the effectiveness of IVIG treatment in severe COVID-19 patients. METHODS: This retrospective multicentre study evaluated 28-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiao, Chen, Yizhu, Li, Ranran, Wu, Zhixiong, Xu, Qianghong, Li, Zhongyi, Annane, Djillali, Feng, Huibin, Huang, Sisi, Guo, Jun, Zhang, Lidi, Ye, Xiaofei, Zhu, Wei, Du, Hangxiang, Liu, Yong'an, Wang, Tao, Chen, Limin, Wen, Zhenliang, Teboul, Jean-Louis, Chen, Dechang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131555/
https://www.ncbi.nlm.nih.gov/pubmed/34020032
http://dx.doi.org/10.1016/j.cmi.2021.05.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131555/
https://www.ncbi.nlm.nih.gov/pubmed/34020032
http://dx.doi.org/10.1016/j.cmi.2021.05.012

Ejemplares similares